Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 785.20
-9.30 (-1.17%)
May 15, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Revenue
Revenue (ttm)
$7.45M
Revenue Growth
n/a
P/S Ratio
41.91
Revenue / Employee
$1.86M
Employees
4
Market Cap
312.07M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| SofWave Medical | 235.09M |
| Ilex Medical | 920.37M |
| BrainsWay | 161.81M |
Oramed Pharmaceuticals News
- 18 days ago - Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical - Seeking Alpha
- 18 days ago - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - GlobeNewsWire
- 18 days ago - Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - PRNewsWire
- 2 months ago - Oramed Pharmaceuticals Issues Letter to Shareholders - PRNewsWire
- 2 months ago - Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock - Benzinga
- 3 months ago - Oramed announces spinoff of protein drug technology - Seeking Alpha
- 3 months ago - Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin - PRNewsWire
- 7 months ago - Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PRNewsWire